Skip to main content
Erschienen in: Breast Cancer Research and Treatment 3/2016

07.09.2016 | Epidemiology

A prospective study of endometriosis and risk of benign breast disease

verfasst von: Leslie V. Farland, Rulla M. Tamimi, A. Heather Eliassen, Donna Spiegelman, Laura C. Collins, Stuart J. Schnitt, Stacey A. Missmer

Erschienen in: Breast Cancer Research and Treatment | Ausgabe 3/2016

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Given the altered hormonal and inflammatory environment of women with endometriosis, several studies have suggested a positive association between endometriosis and breast cancer, although findings have been mixed. This study investigates the relationship between endometriosis and benign breast disease (BBD), benign lesions that are associated with an increased risk of breast cancer.

Methods

Among women in the Nurses’ Health Study II followed from 1991–2003 (n = 76,393), we investigated the association between laparoscopically confirmed endometriosis and biopsy-confirmed BBD. Cox proportional hazard models, adjusted for a priori potential confounding factors, were used to calculate hazard ratios (HR) and 95 % confidence intervals (CI). Across follow-up, 2011 BBD biopsies were collected and centrally reviewed by study pathologists (nonproliferative = 675, proliferative = 1336). Effect modification by infertility history and use of screening mammography was investigated.

Results

Endometriosis was associated with a modest increased risk of biopsy-confirmed BBD in crude and multivariable adjusted models (HR 1.20, 95 % CI 1.00–1.43). When evaluating subtypes of BBD, we did not see different associations for nonproliferative or proliferative BBD lesions, as endometriosis was associated with a modest increased risk for both (HR nonproliferative 1.15, 95 % CI 0.84–1.57; HR proliferative 1.22, 95 % CI 0.98–1.52). The association between endometriosis and proliferative BBD appeared strongest among women who had ever experienced infertility (HR 1.50, 95 % CI 1.12–2.03; P value, test for heterogeneity = 0.05). Sensitivity analyses investigating screening behaviors between those with and without endometriosis did not significantly alter results.

Conclusion

Endometriosis was associated with a modest increased risk of both proliferative and nonproliferative BBD, although future work should replicate this novel finding.
Literatur
1.
Zurück zum Zitat American Cancer Society I (2013) Breast cancer facts and figures 2013-2014. Atlanta American Cancer Society I (2013) Breast cancer facts and figures 2013-2014. Atlanta
2.
Zurück zum Zitat Page DL, Dupont WD, Rogers LW, Rados MS (1985) Atypical hyperplastic lesions of the female breast. A long-term follow-up study. Cancer 55(11):2698–2708CrossRefPubMed Page DL, Dupont WD, Rogers LW, Rados MS (1985) Atypical hyperplastic lesions of the female breast. A long-term follow-up study. Cancer 55(11):2698–2708CrossRefPubMed
3.
Zurück zum Zitat London SJ, Connolly JL, Schnitt SJ, Colditz GA (1992) A prospective study of benign breast disease and the risk of breast cancer. JAMA 267(7):941–944CrossRefPubMed London SJ, Connolly JL, Schnitt SJ, Colditz GA (1992) A prospective study of benign breast disease and the risk of breast cancer. JAMA 267(7):941–944CrossRefPubMed
4.
Zurück zum Zitat Carter CL, Corle DK, Micozzi MS, Schatzkin A, Taylor PR (1988) A prospective study of the development of breast cancer in 16,692 women with benign breast disease. Am J Epidemiol 128(3):467–477PubMed Carter CL, Corle DK, Micozzi MS, Schatzkin A, Taylor PR (1988) A prospective study of the development of breast cancer in 16,692 women with benign breast disease. Am J Epidemiol 128(3):467–477PubMed
5.
Zurück zum Zitat Collins LC, Baer HJ, Tamimi RM, Connolly JL, Colditz GA, Schnitt SJ (2007) Magnitude and laterality of breast cancer risk according to histologic type of atypical hyperplasia: results from the Nurses’ Health Study. Cancer 109(2):180–187. doi:10.1002/cncr.22408 CrossRefPubMed Collins LC, Baer HJ, Tamimi RM, Connolly JL, Colditz GA, Schnitt SJ (2007) Magnitude and laterality of breast cancer risk according to histologic type of atypical hyperplasia: results from the Nurses’ Health Study. Cancer 109(2):180–187. doi:10.​1002/​cncr.​22408 CrossRefPubMed
8.
Zurück zum Zitat Missmer SA, Cramer DW (2003) The epidemiology of endometriosis. Obstet Gynecol Clin North Am 30(1):1–19, viiCrossRefPubMed Missmer SA, Cramer DW (2003) The epidemiology of endometriosis. Obstet Gynecol Clin North Am 30(1):1–19, viiCrossRefPubMed
10.
Zurück zum Zitat Parente Barbosa C, Bentes De Souza AM, Bianco B, Christofolini DM (2011) The effect of hormones on endometriosis development. Minerva Ginecol 63(4):375–386PubMed Parente Barbosa C, Bentes De Souza AM, Bianco B, Christofolini DM (2011) The effect of hormones on endometriosis development. Minerva Ginecol 63(4):375–386PubMed
13.
Zurück zum Zitat Weiss HA, Brinton LA, Potischman NA, Brogan D, Coates RJ, Gammon MD, Malone KE, Schoenberg JB (1999) Breast cancer risk in young women and history of selected medical conditions. Int J Epidemiol 28(5):816–823CrossRefPubMed Weiss HA, Brinton LA, Potischman NA, Brogan D, Coates RJ, Gammon MD, Malone KE, Schoenberg JB (1999) Breast cancer risk in young women and history of selected medical conditions. Int J Epidemiol 28(5):816–823CrossRefPubMed
14.
Zurück zum Zitat Borgfeldt C, Andolf E (2004) Cancer risk after hospital discharge diagnosis of benign ovarian cysts and endometriosis. Acta Obstet Gynecol Scand 83(4):395–400CrossRefPubMed Borgfeldt C, Andolf E (2004) Cancer risk after hospital discharge diagnosis of benign ovarian cysts and endometriosis. Acta Obstet Gynecol Scand 83(4):395–400CrossRefPubMed
15.
Zurück zum Zitat Brinton LA, Gridley G, Persson I, Baron J, Bergqvist A (1997) Cancer risk after a hospital discharge diagnosis of endometriosis. Am J Obstet Gynecol 176(3):572–579CrossRefPubMed Brinton LA, Gridley G, Persson I, Baron J, Bergqvist A (1997) Cancer risk after a hospital discharge diagnosis of endometriosis. Am J Obstet Gynecol 176(3):572–579CrossRefPubMed
17.
Zurück zum Zitat Moseson M, Koenig KL, Shore RE, Pasternack BS (1993) The influence of medical conditions associated with hormones on the risk of breast cancer. Int J Epidemiol 22(6):1000–1009CrossRefPubMed Moseson M, Koenig KL, Shore RE, Pasternack BS (1993) The influence of medical conditions associated with hormones on the risk of breast cancer. Int J Epidemiol 22(6):1000–1009CrossRefPubMed
18.
Zurück zum Zitat Schairer C, Persson I, Falkeborn M, Naessen T, Troisi R, Brinton LA (1997) Breast cancer risk associated with gynecologic surgery and indications for such surgery. Int J Cancer 70(2):150–154CrossRefPubMed Schairer C, Persson I, Falkeborn M, Naessen T, Troisi R, Brinton LA (1997) Breast cancer risk associated with gynecologic surgery and indications for such surgery. Int J Cancer 70(2):150–154CrossRefPubMed
19.
Zurück zum Zitat Kok VC, Tsai HJ, Su CF, Lee CK (2015) The risks for ovarian, endometrial, breast, colorectal, and other cancers in women with newly diagnosed endometriosis or adenomyosis: a population-based study. Int J Gynecol Cancer 25(6):968–976. doi:10.1097/IGC.0000000000000454 CrossRefPubMed Kok VC, Tsai HJ, Su CF, Lee CK (2015) The risks for ovarian, endometrial, breast, colorectal, and other cancers in women with newly diagnosed endometriosis or adenomyosis: a population-based study. Int J Gynecol Cancer 25(6):968–976. doi:10.​1097/​IGC.​0000000000000454​ CrossRefPubMed
20.
Zurück zum Zitat Nichols HB, Visvanathan K, Newcomb PA, Hampton JM, Egan KM, Titus-Ernstoff L, Trentham-Dietz A (2011) Bilateral oophorectomy in relation to risk of postmenopausal breast cancer: confounding by nonmalignant indications for surgery? Am J Epidemiol 173(10):1111–1120. doi:10.1093/aje/kwq510 CrossRefPubMedPubMedCentral Nichols HB, Visvanathan K, Newcomb PA, Hampton JM, Egan KM, Titus-Ernstoff L, Trentham-Dietz A (2011) Bilateral oophorectomy in relation to risk of postmenopausal breast cancer: confounding by nonmalignant indications for surgery? Am J Epidemiol 173(10):1111–1120. doi:10.​1093/​aje/​kwq510 CrossRefPubMedPubMedCentral
22.
Zurück zum Zitat Farland LV, Tamimi RM, Eliassen AH, Spiegelman D, Hankinson SE, Chen WY, Missmer SA (in press) The relationship between laparoscopically confirmed endometriosis and breast cancer in the nurses’ health study II. Obstet Gynecol Farland LV, Tamimi RM, Eliassen AH, Spiegelman D, Hankinson SE, Chen WY, Missmer SA (in press) The relationship between laparoscopically confirmed endometriosis and breast cancer in the nurses’ health study II. Obstet Gynecol
23.
Zurück zum Zitat Bertelsen L, Mellemkjaer L, Frederiksen K, Kjaer SK, Brinton LA, Sakoda LC, van Valkengoed I, Olsen JH (2007) Risk for breast cancer among women with endometriosis. Int J Cancer 120(6):1372–1375. doi:10.1002/ijc.22490 CrossRefPubMed Bertelsen L, Mellemkjaer L, Frederiksen K, Kjaer SK, Brinton LA, Sakoda LC, van Valkengoed I, Olsen JH (2007) Risk for breast cancer among women with endometriosis. Int J Cancer 120(6):1372–1375. doi:10.​1002/​ijc.​22490 CrossRefPubMed
25.
Zurück zum Zitat Olson JE, Cerhan JR, Janney CA, Anderson KE, Vachon CM, Sellers TA (2002) Postmenopausal cancer risk after self-reported endometriosis diagnosis in the Iowa Women’s Health Study. Cancer 94(5):1612–1618. doi:10.1002/cncr.10370 CrossRefPubMed Olson JE, Cerhan JR, Janney CA, Anderson KE, Vachon CM, Sellers TA (2002) Postmenopausal cancer risk after self-reported endometriosis diagnosis in the Iowa Women’s Health Study. Cancer 94(5):1612–1618. doi:10.​1002/​cncr.​10370 CrossRefPubMed
27.
Zurück zum Zitat Matta JL, Flores I, Morales LM, Monteiro J, Alvarez-Garriga C, Bayona M (2013) Women with endometriosis have a higher DNA repair capacity and diminished breast cancer risk. Mol Cancer Biol. doi:10.9777/mcb.2013.10005 Matta JL, Flores I, Morales LM, Monteiro J, Alvarez-Garriga C, Bayona M (2013) Women with endometriosis have a higher DNA repair capacity and diminished breast cancer risk. Mol Cancer Biol. doi:10.​9777/​mcb.​2013.​10005
28.
Zurück zum Zitat Baron JA, Weiderpass E, Newcomb PA, Stampfer M, Titus-Ernstoff L, Egan KM, Greenberg ER (2001) Metabolic disorders and breast cancer risk (United States). Cancer Causes Control 12(10):875–880CrossRefPubMed Baron JA, Weiderpass E, Newcomb PA, Stampfer M, Titus-Ernstoff L, Egan KM, Greenberg ER (2001) Metabolic disorders and breast cancer risk (United States). Cancer Causes Control 12(10):875–880CrossRefPubMed
29.
Zurück zum Zitat Brinton LA, Westhoff CL, Scoccia B, Lamb EJ, Althuis MD, Mabie JE, Moghissi KS (2005) Causes of infertility as predictors of subsequent cancer risk. Epidemiology 16(4):500–507CrossRefPubMed Brinton LA, Westhoff CL, Scoccia B, Lamb EJ, Althuis MD, Mabie JE, Moghissi KS (2005) Causes of infertility as predictors of subsequent cancer risk. Epidemiology 16(4):500–507CrossRefPubMed
31.
33.
Zurück zum Zitat Lunn M, McNeil D (1995) Applying Cox regression to competing risks. Biometrics 51(2):524–532CrossRefPubMed Lunn M, McNeil D (1995) Applying Cox regression to competing risks. Biometrics 51(2):524–532CrossRefPubMed
36.
Zurück zum Zitat Wang J, Costantino JP, Tan-Chiu E, Wickerham DL, Paik S, Wolmark N (2004) Lower-category benign breast disease and the risk of invasive breast cancer. J Natl Cancer Inst 96(8):616–620CrossRefPubMed Wang J, Costantino JP, Tan-Chiu E, Wickerham DL, Paik S, Wolmark N (2004) Lower-category benign breast disease and the risk of invasive breast cancer. J Natl Cancer Inst 96(8):616–620CrossRefPubMed
37.
Zurück zum Zitat Hartmann LC, Sellers TA, Frost MH, Lingle WL, Degnim AC, Ghosh K, Vierkant RA, Maloney SD, Pankratz VS, Hillman DW, Suman VJ, Johnson J, Blake C, Tlsty T, Vachon CM, Melton LJ 3rd, Visscher DW (2005) Benign breast disease and the risk of breast cancer. N Engl J Med 353(3):229–237. doi:10.1056/NEJMoa044383 CrossRefPubMed Hartmann LC, Sellers TA, Frost MH, Lingle WL, Degnim AC, Ghosh K, Vierkant RA, Maloney SD, Pankratz VS, Hillman DW, Suman VJ, Johnson J, Blake C, Tlsty T, Vachon CM, Melton LJ 3rd, Visscher DW (2005) Benign breast disease and the risk of breast cancer. N Engl J Med 353(3):229–237. doi:10.​1056/​NEJMoa044383 CrossRefPubMed
38.
Zurück zum Zitat Castells X, Domingo L, Corominas JM, Tora-Rocamora I, Quintana MJ, Bare M, Vidal C, Natal C, Sanchez M, Saladie F, Ferrer J, Vernet M, Servitja S, Rodriguez-Arana A, Roman M, Espinas JA, Sala M (2015) Breast cancer risk after diagnosis by screening mammography of nonproliferative or proliferative benign breast disease: a study from a population-based screening program. Breast Cancer Res Treat 149(1):237–244. doi:10.1007/s10549-014-3208-z CrossRefPubMed Castells X, Domingo L, Corominas JM, Tora-Rocamora I, Quintana MJ, Bare M, Vidal C, Natal C, Sanchez M, Saladie F, Ferrer J, Vernet M, Servitja S, Rodriguez-Arana A, Roman M, Espinas JA, Sala M (2015) Breast cancer risk after diagnosis by screening mammography of nonproliferative or proliferative benign breast disease: a study from a population-based screening program. Breast Cancer Res Treat 149(1):237–244. doi:10.​1007/​s10549-014-3208-z CrossRefPubMed
40.
Zurück zum Zitat Prescott J, Farland LV, Tobias DK, Gaskins AJ, Spiegelman D, Chavarro JE, Rich-Edwards JW, Barbieri RL, Missmer SA (2016) A prospective cohort study of endometriosis and subsequent risk of infertility. Hum Reprod. doi:10.1093/humrep/dew085 PubMed Prescott J, Farland LV, Tobias DK, Gaskins AJ, Spiegelman D, Chavarro JE, Rich-Edwards JW, Barbieri RL, Missmer SA (2016) A prospective cohort study of endometriosis and subsequent risk of infertility. Hum Reprod. doi:10.​1093/​humrep/​dew085 PubMed
41.
Zurück zum Zitat Agic A, Xu H, Finas D, Banz C, Diedrich K, Hornung D (2006) Is endometriosis associated with systemic subclinical inflammation? Gynecol Obstet Invest 62(3):139–147CrossRefPubMed Agic A, Xu H, Finas D, Banz C, Diedrich K, Hornung D (2006) Is endometriosis associated with systemic subclinical inflammation? Gynecol Obstet Invest 62(3):139–147CrossRefPubMed
42.
Zurück zum Zitat Bruner-Tran KL, Herington JL, Duleba AJ, Taylor HS, Osteen KG (2013) Medical management of endometriosis: emerging evidence linking inflammation to disease pathophysiology. Minerva Ginecol 65(2):199–213PubMedPubMedCentral Bruner-Tran KL, Herington JL, Duleba AJ, Taylor HS, Osteen KG (2013) Medical management of endometriosis: emerging evidence linking inflammation to disease pathophysiology. Minerva Ginecol 65(2):199–213PubMedPubMedCentral
43.
Zurück zum Zitat Samoli E, Trichopoulos D, Lagiou A, Zourna P, Georgila C, Minaki P, Barbouni A, Vassilarou D, Tsikkinis A, Sfikas C, Spanos E, Lagiou P (2013) The hormonal profile of benign breast disease. Br J Cancer 108(1):199–204. doi:10.1038/bjc.2012.493 CrossRefPubMed Samoli E, Trichopoulos D, Lagiou A, Zourna P, Georgila C, Minaki P, Barbouni A, Vassilarou D, Tsikkinis A, Sfikas C, Spanos E, Lagiou P (2013) The hormonal profile of benign breast disease. Br J Cancer 108(1):199–204. doi:10.​1038/​bjc.​2012.​493 CrossRefPubMed
44.
Zurück zum Zitat Kenneth J, Rothman SG, Lash Timothy L (2008) Modern Epidemiology, 3rd edn. Lippincott Williams & Wilkins, Philidelphia Kenneth J, Rothman SG, Lash Timothy L (2008) Modern Epidemiology, 3rd edn. Lippincott Williams & Wilkins, Philidelphia
45.
Zurück zum Zitat Zondervan KT, Cardon LR, Kennedy SH (2002) What makes a good case-control study? Design issues for complex traits such as endometriosis. Hum Reprod 17(6):1415–1423CrossRefPubMed Zondervan KT, Cardon LR, Kennedy SH (2002) What makes a good case-control study? Design issues for complex traits such as endometriosis. Hum Reprod 17(6):1415–1423CrossRefPubMed
Metadaten
Titel
A prospective study of endometriosis and risk of benign breast disease
verfasst von
Leslie V. Farland
Rulla M. Tamimi
A. Heather Eliassen
Donna Spiegelman
Laura C. Collins
Stuart J. Schnitt
Stacey A. Missmer
Publikationsdatum
07.09.2016
Verlag
Springer US
Erschienen in
Breast Cancer Research and Treatment / Ausgabe 3/2016
Print ISSN: 0167-6806
Elektronische ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-016-3957-y

Weitere Artikel der Ausgabe 3/2016

Breast Cancer Research and Treatment 3/2016 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.